ID

14081

Description

Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT01912404

Link

https://clinicaltrials.gov/show/NCT01912404

Keywords

  1. 3/28/16 3/28/16 -
Uploaded on

March 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Alcoholic Hepatitis NCT01912404

Eligibility Alcoholic Hepatitis NCT01912404

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients 21 years of age or older
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
patients with alcoholic hepatitis defined as:
Description

alcoholic hepatitis

Data type

boolean

Alias
UMLS CUI [1]
C0019187
history of heavy alcohol abuse use: >40 g/day in females and >60 g/day in males for a minimum period of 6 months
Description

heavy alcohol abuse

Data type

boolean

Alias
UMLS CUI [1]
C0740861
consumed alcohol within 6 weeks of entry into the study
Description

alcohol consumed

Data type

boolean

Alias
UMLS CUI [1]
C3700016
biochemical parameters of severe disease as evidenced by meld score >20 but <35, or meld score 35-40 if the sofa score is <10
Description

severe disease

Data type

boolean

Alias
UMLS CUI [1]
C1718072
UMLS CUI [2]
C3494459
patients with established contraindications to steroid use including but not limited to the following:
Description

Steroids

Data type

boolean

Alias
UMLS CUI [1]
C0038317
gi bleed
Description

Gastrointestinal Hemorrhage

Data type

boolean

Alias
UMLS CUI [1]
C0017181
active infection, including spontaneous bacterial peritonitis, based on positive blood culture, urine culture, or chest x-ray (if positive, must have been on antibiotics for at least 24 hours prior to study entry)
Description

infection

Data type

boolean

Alias
UMLS CUI [1]
C0009450
acute pancreatitis (increased lipase > 3x uln or radiologic evidence)
Description

Acute pancreatitis

Data type

boolean

Alias
UMLS CUI [1]
C0001339
positivity for hepatitis b (hbsag+) or c virus (hcv+), and
Description

hepatitis b + c

Data type

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0220847
renal failure
Description

Kidney Failure

Data type

boolean

Alias
UMLS CUI [1]
C0035078
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
other or concomitant cause of liver disease as a result of:
Description

concomitant disease

Data type

boolean

Alias
UMLS CUI [1]
C0243087
autoimmune liver disease (positive anti-mitochondrial antibody and smooth muscle antibody, positive reading on anti-nuclear antibody titer >1:160)
Description

Autoimmune liver disease

Data type

boolean

Alias
UMLS CUI [1]
C0400936
metabolic liver disease (abnormal ceruloplasmin levels)
Description

Metabolic liver diseases

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0311400
vascular liver disease
Description

vascular liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C1801960
drug induced liver disease
Description

Drug-Induced Liver Injury

Data type

boolean

Alias
UMLS CUI [1]
C0860207
sepsis as evidenced by positive blood or urine culture, pneumonia as confirmed by x-ray
Description

Sepsis

Data type

boolean

Alias
UMLS CUI [1]
C0243026
history of renal transplant and/or on dialysis at time of entry into study
Description

History of renal transplant

Data type

boolean

Alias
UMLS CUI [1]
C0455641
diagnosed or suspected systemic lupus erythematosus (sle) and/or rheumatoid arthritis (ra)
Description

systemic lupus erythematosus

Data type

boolean

Alias
UMLS CUI [1]
C0024141
hepatocellular carcinoma (hcc) at entry into the study
Description

Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C2239176
active non-liver malignancies other than curatively treated skin cancer (basal cell or squamous cell carcinomas)
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
liver biopsy, if carried out, showing findings not compatible with alcoholic hepatitis
Description

Biopsy of liver

Data type

boolean

Alias
UMLS CUI [1]
C0193388

Similar models

Eligibility Alcoholic Hepatitis NCT01912404

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female patients 21 years of age or older
boolean
C0001779 (UMLS CUI [1])
alcoholic hepatitis
Item
patients with alcoholic hepatitis defined as:
boolean
C0019187 (UMLS CUI [1])
heavy alcohol abuse
Item
history of heavy alcohol abuse use: >40 g/day in females and >60 g/day in males for a minimum period of 6 months
boolean
C0740861 (UMLS CUI [1])
alcohol consumed
Item
consumed alcohol within 6 weeks of entry into the study
boolean
C3700016 (UMLS CUI [1])
severe disease
Item
biochemical parameters of severe disease as evidenced by meld score >20 but <35, or meld score 35-40 if the sofa score is <10
boolean
C1718072 (UMLS CUI [1])
C3494459 (UMLS CUI [2])
Steroids
Item
patients with established contraindications to steroid use including but not limited to the following:
boolean
C0038317 (UMLS CUI [1])
Gastrointestinal Hemorrhage
Item
gi bleed
boolean
C0017181 (UMLS CUI [1])
infection
Item
active infection, including spontaneous bacterial peritonitis, based on positive blood culture, urine culture, or chest x-ray (if positive, must have been on antibiotics for at least 24 hours prior to study entry)
boolean
C0009450 (UMLS CUI [1])
Acute pancreatitis
Item
acute pancreatitis (increased lipase > 3x uln or radiologic evidence)
boolean
C0001339 (UMLS CUI [1])
hepatitis b + c
Item
positivity for hepatitis b (hbsag+) or c virus (hcv+), and
boolean
C0149709 (UMLS CUI [1])
C0220847 (UMLS CUI [2])
Kidney Failure
Item
renal failure
boolean
C0035078 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
concomitant disease
Item
other or concomitant cause of liver disease as a result of:
boolean
C0243087 (UMLS CUI [1])
Autoimmune liver disease
Item
autoimmune liver disease (positive anti-mitochondrial antibody and smooth muscle antibody, positive reading on anti-nuclear antibody titer >1:160)
boolean
C0400936 (UMLS CUI [1])
Metabolic liver diseases
Item
metabolic liver disease (abnormal ceruloplasmin levels)
boolean
C0023895 (UMLS CUI [1,1])
C0311400 (UMLS CUI [1,2])
vascular liver disease
Item
vascular liver disease
boolean
C0023895 (UMLS CUI [1,1])
C1801960 (UMLS CUI [1,2])
Drug-Induced Liver Injury
Item
drug induced liver disease
boolean
C0860207 (UMLS CUI [1])
Sepsis
Item
sepsis as evidenced by positive blood or urine culture, pneumonia as confirmed by x-ray
boolean
C0243026 (UMLS CUI [1])
History of renal transplant
Item
history of renal transplant and/or on dialysis at time of entry into study
boolean
C0455641 (UMLS CUI [1])
systemic lupus erythematosus
Item
diagnosed or suspected systemic lupus erythematosus (sle) and/or rheumatoid arthritis (ra)
boolean
C0024141 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma (hcc) at entry into the study
boolean
C2239176 (UMLS CUI [1])
Malignant Neoplasms
Item
active non-liver malignancies other than curatively treated skin cancer (basal cell or squamous cell carcinomas)
boolean
C0006826 (UMLS CUI [1])
Biopsy of liver
Item
liver biopsy, if carried out, showing findings not compatible with alcoholic hepatitis
boolean
C0193388 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial